Patent · US Active

Nanochanneled device and related methods

US8632510B2 · kind B2 · utility

3Cited by
22References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 13, 2010
Grant dateJan 21, 2014
Priority date
Expiry dateApr 13, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T156/1064
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A capsule configured for in vivo refilling of a thereapeutic agent. In certain embodiments, the capsule may contain methotrexate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.